Home/Filings/4/0001171843-25-002084
4//SEC Filing

Lerner Neil 4

Accession 0001171843-25-002084

CIK 0001738021other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 9:25 AM ET

Size

5.2 KB

Accession

0001171843-25-002084

Insider Transaction Report

Form 4
Period: 2025-04-07
Lerner Neil
Chief Accounting Officer
Transactions
  • Purchase

    Common Stock

    2025-04-07$1.42/sh+20,000$28,400320,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.43 per share. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased and prices within the range set forth above.

Documents

1 file

Issuer

Compass Therapeutics, Inc.

CIK 0001738021

Entity typeother

Related Parties

1
  • filerCIK 0001505148

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 9:25 AM ET
Size
5.2 KB